HEADER TRANSFERASE 20-SEP-03 1R0E TITLE GLYCOGEN SYNTHASE KINASE-3 BETA IN COMPLEX WITH 3-INDOLYL-4- TITLE 2 ARYLMALEIMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HI5; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS SER/THR PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.ALLARD,T.NIKOLCHEVA,L.GONG,J.WANG,P.DUNTEN,Z.AVNUR,R.WATERS,Q.SUN, AUTHOR 2 B.SKINNER REVDAT 3 23-AUG-23 1R0E 1 REMARK SEQADV REVDAT 2 24-FEB-09 1R0E 1 VERSN REVDAT 1 12-OCT-04 1R0E 0 JRNL AUTH J.ALLARD,T.NIKOLCHEVA,L.GONG,J.WANG,P.DUNTEN,Z.AVNUR, JRNL AUTH 2 R.WATERS,Q.SUN,B.SKINNER JRNL TITL FROM GENETICS TO THERAPEUTICS: THE WNT PATHWAY AND JRNL TITL 2 OSTEOPOROSIS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 91.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 60349 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3062 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4221 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2810 REMARK 3 BIN FREE R VALUE SET COUNT : 207 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5494 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 185 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.13000 REMARK 3 B22 (A**2) : 1.23000 REMARK 3 B33 (A**2) : -2.36000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.211 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.184 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.131 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.225 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5752 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7840 ; 1.268 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 684 ; 5.680 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 872 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4392 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2649 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 327 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.161 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.070 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3466 ; 0.783 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5670 ; 1.511 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2286 ; 2.036 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2170 ; 3.403 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R0E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020286. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60350 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04600 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.36800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1H8F REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.25 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, AMMONIUM FLUORIDE, PH 7.4, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.97850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.10000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.00450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 90.10000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.97850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.00450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL UNIT IS REMARK 300 UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 30 REMARK 465 ALA A 31 REMARK 465 MET A 32 REMARK 465 SER A 33 REMARK 465 LEU A 34 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 LYS A 122 REMARK 465 LYS A 123 REMARK 465 ASP A 124 REMARK 465 ILE A 384 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 GLY B 30 REMARK 465 ALA B 31 REMARK 465 MET B 32 REMARK 465 SER B 33 REMARK 465 LEU B 34 REMARK 465 GLY B 120 REMARK 465 GLU B 121 REMARK 465 LYS B 122 REMARK 465 LYS B 123 REMARK 465 ASP B 124 REMARK 465 ILE B 384 REMARK 465 GLN B 385 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 91 CG CD CE NZ REMARK 470 ARG B 92 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 260 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 264 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 105 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 233 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 49 72.51 -66.55 REMARK 500 ASN A 64 115.63 -160.30 REMARK 500 PHE A 67 -8.89 -57.85 REMARK 500 ASP A 181 52.18 -163.72 REMARK 500 ASP A 200 85.11 58.42 REMARK 500 CYS A 218 148.07 82.34 REMARK 500 ARG A 220 131.22 -37.68 REMARK 500 TYR A 221 -34.60 91.63 REMARK 500 ASN A 370 69.50 -166.32 REMARK 500 ASP B 49 79.61 -65.12 REMARK 500 ASN B 64 98.08 -161.61 REMARK 500 ASP B 181 50.59 -155.65 REMARK 500 ASP B 200 85.48 55.10 REMARK 500 CYS B 218 147.78 84.81 REMARK 500 ARG B 220 130.18 -35.52 REMARK 500 TYR B 221 -35.24 91.14 REMARK 500 THR B 309 116.96 -34.19 REMARK 500 ASN B 370 66.30 -170.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FLC A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFN A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DFN B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H8F RELATED DB: PDB REMARK 900 GSK-3 BETA WITH NO SUBSTRATES OR INHIBITORS DBREF 1R0E A 35 420 UNP P49841 GSK3B_HUMAN 35 420 DBREF 1R0E B 35 420 UNP P49841 GSK3B_HUMAN 35 420 SEQADV 1R0E GLY A 30 UNP P49841 CLONING ARTIFACT SEQADV 1R0E ALA A 31 UNP P49841 CLONING ARTIFACT SEQADV 1R0E MET A 32 UNP P49841 CLONING ARTIFACT SEQADV 1R0E SER A 33 UNP P49841 CLONING ARTIFACT SEQADV 1R0E LEU A 34 UNP P49841 CLONING ARTIFACT SEQADV 1R0E GLY B 30 UNP P49841 CLONING ARTIFACT SEQADV 1R0E ALA B 31 UNP P49841 CLONING ARTIFACT SEQADV 1R0E MET B 32 UNP P49841 CLONING ARTIFACT SEQADV 1R0E SER B 33 UNP P49841 CLONING ARTIFACT SEQADV 1R0E LEU B 34 UNP P49841 CLONING ARTIFACT SEQRES 1 A 391 GLY ALA MET SER LEU SER LYS VAL THR THR VAL VAL ALA SEQRES 2 A 391 THR PRO GLY GLN GLY PRO ASP ARG PRO GLN GLU VAL SER SEQRES 3 A 391 TYR THR ASP THR LYS VAL ILE GLY ASN GLY SER PHE GLY SEQRES 4 A 391 VAL VAL TYR GLN ALA LYS LEU CYS ASP SER GLY GLU LEU SEQRES 5 A 391 VAL ALA ILE LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS SEQRES 6 A 391 ASN ARG GLU LEU GLN ILE MET ARG LYS LEU ASP HIS CYS SEQRES 7 A 391 ASN ILE VAL ARG LEU ARG TYR PHE PHE TYR SER SER GLY SEQRES 8 A 391 GLU LYS LYS ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP SEQRES 9 A 391 TYR VAL PRO GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SEQRES 10 A 391 SER ARG ALA LYS GLN THR LEU PRO VAL ILE TYR VAL LYS SEQRES 11 A 391 LEU TYR MET TYR GLN LEU PHE ARG SER LEU ALA TYR ILE SEQRES 12 A 391 HIS SER PHE GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN SEQRES 13 A 391 ASN LEU LEU LEU ASP PRO ASP THR ALA VAL LEU LYS LEU SEQRES 14 A 391 CYS ASP PHE GLY SER ALA LYS GLN LEU VAL ARG GLY GLU SEQRES 15 A 391 PRO ASN VAL SER TYR ILE CYS SER ARG TYR TYR ARG ALA SEQRES 16 A 391 PRO GLU LEU ILE PHE GLY ALA THR ASP TYR THR SER SER SEQRES 17 A 391 ILE ASP VAL TRP SER ALA GLY CYS VAL LEU ALA GLU LEU SEQRES 18 A 391 LEU LEU GLY GLN PRO ILE PHE PRO GLY ASP SER GLY VAL SEQRES 19 A 391 ASP GLN LEU VAL GLU ILE ILE LYS VAL LEU GLY THR PRO SEQRES 20 A 391 THR ARG GLU GLN ILE ARG GLU MET ASN PRO ASN TYR THR SEQRES 21 A 391 GLU PHE LYS PHE PRO GLN ILE LYS ALA HIS PRO TRP THR SEQRES 22 A 391 LYS VAL PHE ARG PRO ARG THR PRO PRO GLU ALA ILE ALA SEQRES 23 A 391 LEU CYS SER ARG LEU LEU GLU TYR THR PRO THR ALA ARG SEQRES 24 A 391 LEU THR PRO LEU GLU ALA CYS ALA HIS SER PHE PHE ASP SEQRES 25 A 391 GLU LEU ARG ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG SEQRES 26 A 391 ASP THR PRO ALA LEU PHE ASN PHE THR THR GLN GLU LEU SEQRES 27 A 391 SER SER ASN PRO PRO LEU ALA THR ILE LEU ILE PRO PRO SEQRES 28 A 391 HIS ALA ARG ILE GLN ALA ALA ALA SER THR PRO THR ASN SEQRES 29 A 391 ALA THR ALA ALA SER ASP ALA ASN THR GLY ASP ARG GLY SEQRES 30 A 391 GLN THR ASN ASN ALA ALA SER ALA SER ALA SER ASN SER SEQRES 31 A 391 THR SEQRES 1 B 391 GLY ALA MET SER LEU SER LYS VAL THR THR VAL VAL ALA SEQRES 2 B 391 THR PRO GLY GLN GLY PRO ASP ARG PRO GLN GLU VAL SER SEQRES 3 B 391 TYR THR ASP THR LYS VAL ILE GLY ASN GLY SER PHE GLY SEQRES 4 B 391 VAL VAL TYR GLN ALA LYS LEU CYS ASP SER GLY GLU LEU SEQRES 5 B 391 VAL ALA ILE LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS SEQRES 6 B 391 ASN ARG GLU LEU GLN ILE MET ARG LYS LEU ASP HIS CYS SEQRES 7 B 391 ASN ILE VAL ARG LEU ARG TYR PHE PHE TYR SER SER GLY SEQRES 8 B 391 GLU LYS LYS ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP SEQRES 9 B 391 TYR VAL PRO GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SEQRES 10 B 391 SER ARG ALA LYS GLN THR LEU PRO VAL ILE TYR VAL LYS SEQRES 11 B 391 LEU TYR MET TYR GLN LEU PHE ARG SER LEU ALA TYR ILE SEQRES 12 B 391 HIS SER PHE GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN SEQRES 13 B 391 ASN LEU LEU LEU ASP PRO ASP THR ALA VAL LEU LYS LEU SEQRES 14 B 391 CYS ASP PHE GLY SER ALA LYS GLN LEU VAL ARG GLY GLU SEQRES 15 B 391 PRO ASN VAL SER TYR ILE CYS SER ARG TYR TYR ARG ALA SEQRES 16 B 391 PRO GLU LEU ILE PHE GLY ALA THR ASP TYR THR SER SER SEQRES 17 B 391 ILE ASP VAL TRP SER ALA GLY CYS VAL LEU ALA GLU LEU SEQRES 18 B 391 LEU LEU GLY GLN PRO ILE PHE PRO GLY ASP SER GLY VAL SEQRES 19 B 391 ASP GLN LEU VAL GLU ILE ILE LYS VAL LEU GLY THR PRO SEQRES 20 B 391 THR ARG GLU GLN ILE ARG GLU MET ASN PRO ASN TYR THR SEQRES 21 B 391 GLU PHE LYS PHE PRO GLN ILE LYS ALA HIS PRO TRP THR SEQRES 22 B 391 LYS VAL PHE ARG PRO ARG THR PRO PRO GLU ALA ILE ALA SEQRES 23 B 391 LEU CYS SER ARG LEU LEU GLU TYR THR PRO THR ALA ARG SEQRES 24 B 391 LEU THR PRO LEU GLU ALA CYS ALA HIS SER PHE PHE ASP SEQRES 25 B 391 GLU LEU ARG ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG SEQRES 26 B 391 ASP THR PRO ALA LEU PHE ASN PHE THR THR GLN GLU LEU SEQRES 27 B 391 SER SER ASN PRO PRO LEU ALA THR ILE LEU ILE PRO PRO SEQRES 28 B 391 HIS ALA ARG ILE GLN ALA ALA ALA SER THR PRO THR ASN SEQRES 29 B 391 ALA THR ALA ALA SER ASP ALA ASN THR GLY ASP ARG GLY SEQRES 30 B 391 GLN THR ASN ASN ALA ALA SER ALA SER ALA SER ASN SER SEQRES 31 B 391 THR HET FLC A 701 13 HET DFN A 702 30 HET FLC B 601 13 HET DFN B 501 30 HETNAM FLC CITRATE ANION HETNAM DFN 3-[3-(2,3-DIHYDROXY-PROPYLAMINO)-PHENYL]-4-(5-FLUORO-1- HETNAM 2 DFN METHYL-1H-INDOL-3-YL)-PYRROLE-2,5-DIONE FORMUL 3 FLC 2(C6 H5 O7 3-) FORMUL 4 DFN 2(C22 H20 F N3 O4) FORMUL 7 HOH *185(H2 O) HELIX 1 1 ASN A 95 LYS A 103 1 9 HELIX 2 2 VAL A 139 ALA A 149 1 11 HELIX 3 3 PRO A 154 PHE A 175 1 22 HELIX 4 4 LYS A 183 GLN A 185 5 3 HELIX 5 5 ALA A 224 PHE A 229 1 6 HELIX 6 6 SER A 236 GLY A 253 1 18 HELIX 7 7 SER A 261 GLY A 274 1 14 HELIX 8 8 THR A 277 ASN A 285 1 9 HELIX 9 9 PRO A 286 THR A 289 5 4 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 LEU A 321 1 12 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 PHE A 339 5 3 HELIX 15 15 PHE A 340 ASP A 345 1 6 HELIX 16 16 THR A 363 SER A 368 1 6 HELIX 17 17 ASN A 370 PRO A 372 5 3 HELIX 18 18 LEU A 373 ILE A 378 1 6 HELIX 19 19 PRO A 379 ARG A 383 5 5 HELIX 20 20 ASN B 95 LEU B 104 1 10 HELIX 21 21 VAL B 139 ALA B 149 1 11 HELIX 22 22 PRO B 154 PHE B 175 1 22 HELIX 23 23 LYS B 183 GLN B 185 5 3 HELIX 24 24 ALA B 224 PHE B 229 1 6 HELIX 25 25 SER B 236 GLY B 253 1 18 HELIX 26 26 SER B 261 GLY B 274 1 14 HELIX 27 27 THR B 277 ASN B 285 1 9 HELIX 28 28 PRO B 286 THR B 289 5 4 HELIX 29 29 PRO B 300 PHE B 305 1 6 HELIX 30 30 PRO B 310 LEU B 321 1 12 HELIX 31 31 THR B 324 ARG B 328 5 5 HELIX 32 32 THR B 330 ALA B 336 1 7 HELIX 33 33 HIS B 337 ASP B 345 5 9 HELIX 34 34 THR B 363 SER B 368 1 6 HELIX 35 35 ASN B 370 PRO B 372 5 3 HELIX 36 36 LEU B 373 ILE B 378 1 6 HELIX 37 37 PRO B 379 ARG B 383 5 5 SHEET 1 A 7 VAL A 37 PRO A 44 0 SHEET 2 A 7 GLN A 52 GLY A 65 -1 O VAL A 54 N VAL A 40 SHEET 3 A 7 GLY A 68 LEU A 75 -1 O LYS A 74 N THR A 57 SHEET 4 A 7 LEU A 81 LEU A 88 -1 O VAL A 82 N ALA A 73 SHEET 5 A 7 TYR A 127 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 A 7 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 7 A 7 VAL A 37 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 B 3 GLU A 137 THR A 138 0 SHEET 2 B 3 LEU A 187 LEU A 189 -1 O LEU A 189 N GLU A 137 SHEET 3 B 3 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 C 2 ILE A 177 CYS A 178 0 SHEET 2 C 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 D 7 VAL B 37 PRO B 44 0 SHEET 2 D 7 GLN B 52 GLY B 65 -1 O VAL B 54 N VAL B 40 SHEET 3 D 7 GLY B 68 LEU B 75 -1 O LYS B 74 N THR B 57 SHEET 4 D 7 LEU B 81 LEU B 88 -1 O ILE B 84 N TYR B 71 SHEET 5 D 7 TYR B 127 ASP B 133 -1 O LEU B 132 N ALA B 83 SHEET 6 D 7 LEU B 112 SER B 118 -1 N PHE B 116 O ASN B 129 SHEET 7 D 7 VAL B 37 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 E 3 GLU B 137 THR B 138 0 SHEET 2 E 3 LEU B 187 LEU B 189 -1 O LEU B 189 N GLU B 137 SHEET 3 E 3 LEU B 196 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 F 2 ILE B 177 CYS B 178 0 SHEET 2 F 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 SITE 1 AC1 6 PHE A 291 LYS A 292 ARG B 96 ARG B 180 SITE 2 AC1 6 LYS B 205 VAL B 214 SITE 1 AC2 6 ARG A 96 ARG A 180 LYS A 205 VAL A 214 SITE 2 AC2 6 PHE B 291 LYS B 292 SITE 1 AC3 21 ILE A 62 GLY A 63 PHE A 67 VAL A 70 SITE 2 AC3 21 ALA A 83 VAL A 110 LEU A 132 ASP A 133 SITE 3 AC3 21 TYR A 134 VAL A 135 PRO A 136 THR A 138 SITE 4 AC3 21 ARG A 141 GLN A 185 ASN A 186 LEU A 188 SITE 5 AC3 21 CYS A 199 ASP A 200 HOH A 707 HOH A 744 SITE 6 AC3 21 HOH A 779 SITE 1 AC4 20 ILE B 62 GLY B 63 PHE B 67 VAL B 70 SITE 2 AC4 20 ALA B 83 VAL B 110 LEU B 132 ASP B 133 SITE 3 AC4 20 TYR B 134 VAL B 135 PRO B 136 THR B 138 SITE 4 AC4 20 ARG B 141 GLN B 185 ASN B 186 LEU B 188 SITE 5 AC4 20 CYS B 199 HOH B 605 HOH B 611 HOH B 649 CRYST1 83.957 84.009 180.200 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011911 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011903 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005549 0.00000